awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28260541-5E85822D-D746-4F85-82EA-88F2C13C892F
Q28260541-5E85822D-D746-4F85-82EA-88F2C13C892F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28260541-5E85822D-D746-4F85-82EA-88F2C13C892F
RAS Synthetic Lethal Screens Revisited: Still Seeking the Elusive Prize?
P2860
Q28260541-5E85822D-D746-4F85-82EA-88F2C13C892F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28260541-5E85822D-D746-4F85-82EA-88F2C13C892F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d39aed4a730a92deba21104883fd4a5433fd6503
P2860
Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study.